http://2010.igem.org/wiki/index.php?title=Special:Contributions/TobiB&feed=atom&limit=50&target=TobiB&year=&month=2010.igem.org - User contributions [en]2024-03-28T15:24:02ZFrom 2010.igem.orgMediaWiki 1.16.5http://2010.igem.org/Team:LMU-Munich/ScheduleTeam:LMU-Munich/Schedule2010-10-25T13:59:18Z<p>TobiB: </p>
<hr />
<div>{{:Team:LMU-Munich/Templates/Page Header}} <br />
==PCR and mutagenesis of the digestion sites==<br />
<br />
<br />
<br />
<b>[[Team:LMU-Munich/Schedule/Primer table|Primer table]] : Primer sequences, intern numeration, Tm</b><br />
<br />
<br />
<br />
<b>PCR1a: replication of Pdu D with mutagenesis [ ] </b><br />
[[Image:PCR1aP.jpg]]<br />
<br />
Primer used:[[Team:LMU-Munich/Schedule/1P1D| 1P1D]],[[Team:LMU-Munich/Schedule/mpduD_rev| mpduD rev]] expected product size: bp<br />
<br />
<br />
<b>PCR1b: replication of Pdu D with mutagenesis [ ] </b><br />
[[Image:PCR1bP.jpg]]<br />
<br />
Primer used:[[Team:LMU-Munich/Schedule/mpduD_fwd| mpduD fwd]],[[Team:LMU-Munich/Schedule/3P2D| 3P2D]] expected product size: bp<br />
<br />
<br />
<b>PCR2: Joining PCR of PduD [ ] </b><br />
[[Image:PCR2P.jpg]]<br />
<br />
Primer used:[[Team:LMU-Munich/Schedule/1P1D| 1P1D]],[[Team:LMU-Munich/Schedule/3P2D| 3P2D]] expected product size: bp<br />
<br />
<br />
<b>PCR3a: replication of Pdu C with mutagenesis [ ] </b><br />
[[Image:PCR3aP.jpg]]<br />
<br />
Primer used:[[Team:LMU-Munich/Schedule/2P1C| 2P1C]],[[Team:LMU-Munich/Schedule/mpduC_rev| mpduC rev]] expected product size: bp<br />
<br />
<br />
<b>PCR3b: replication of Pdu C with mutagenesis [ ] </b><br />
[[Image:PCR3bP.jpg]]<br />
<br />
Primer used:[[Team:LMU-Munich/Schedule/mpduC_fwd| mpduC fwd]],[[Team:LMU-Munich/Schedule/4P2C| 4P2C]] expected product size: bp<br />
<br />
<br />
<b>PCR4: Joining PCR of Pdu C [ ] </b><br />
[[Image:PCR4P.jpg]]<br />
<br />
Primer used:[[Team:LMU-Munich/Schedule/2P1C| 2P1C]],[[Team:LMU-Munich/Schedule/4P2C| 4P2C]] expected product size: bp<br />
<br />
<br />
<b>PCR5: replication of AurF to be joined with Pdu D [ ] </b><br />
[[Image:PCR5P.jpg]]<br />
<br />
Primer used:[[Team:LMU-Munich/Schedule/5P3AD| 5P3AD]],[[Team:LMU-Munich/Schedule/9P4A| 9P4A]] expected product size: bp<br />
<br />
<br />
<b>PCR6a: replication of LctO with mutagenesis [ ] </b><br />
[[Image:PCR6aP.jpg]]<br />
<br />
Primer used:[[Team:LMU-Munich/Schedule/8P3LC| 8P3LC]],[[Team:LMU-Munich/Schedule/m1lctO_rev| m1lctO rev]] expected product size: bp<br />
<br />
<br />
<b>PCR6b: replication of LctO with mutagenesis [ ] </b><br />
[[Image:PCR6bP.jpg]]<br />
<br />
Primer used:[[Team:LMU-Munich/Schedule/m1lctO_fwd| m1lctO fwd]],[[Team:LMU-Munich/Schedule/10P4L| 10P4L]] expected product size: bp<br />
<br />
<br />
<b>PCR7: Joining PCR of LctO [ ] </b><br />
[[Image: PCR7P.jpg]]<br />
<br />
Primer used:[[Team:LMU-Munich/Schedule/8P3LC| 8P3LC]],[[Team:LMU-Munich/Schedule/10P4L| 10P4L]] expected product size: bp<br />
<br />
<br />
<b>PCR8a: replication of LctO with mutagenesis [ ] </b><br />
[[Image:PCR8aP.jpg]]<br />
<br />
Primer used:[[Team:LMU-Munich/Schedule/8P3LC| 8P3LC]],[[Team:LMU-Munich/Schedule/m2lctO_rev| m2lctO rev]] expected product size: bp<br />
<br />
<br />
<b>PCR8b: replication of LctO with mutagenesis [ ] </b><br />
[[Image:PCR8bP.jpg]]<br />
<br />
Primer used:[[Team:LMU-Munich/Schedule/m2lctO_fwd| m2lctO fwd]],[[Team:LMU-Munich/Schedule/10P4L| 10P4L]] expected product size: bp<br />
<br />
<br />
<b>PCR9: Joining PCR of LctO [ ] </b><br />
[[Image:PCR9P.jpg]]<br />
<br />
Primer used:[[Team:LMU-Munich/Schedule/8P3LC| 8P3LC]],[[Team:LMU-Munich/Schedule/10P4L| 10P4L]] expected product size: bp<br />
<br />
<br />
<b>PCR10: Joining PCR of AurF and PduD [ ] </b><br />
[[Image:PCR10P.jpg]]<br />
<br />
Primer used:[[Team:LMU-Munich/Schedule/1P1D| 1P1D]],[[Team:LMU-Munich/Schedule/9P4A| 9P4A]] expected product size: bp<br />
<br />
<br />
<b>PCR11: Joining PCR of LctO and PduC [ ] </b><br />
[[Image:PCR11P.jpg]]<br />
<br />
Primer used:[[Team:LMU-Munich/Schedule/2P1C| 2P1C]],[[Team:LMU-Munich/Schedule/10P4L| 10P4L]] expected product size: bp<br />
<br />
<br />
<b>PCR12a: replication of the Pdu-Operon with mutagenesis [ ] </b><br />
[[Image:PCR12aP.jpg]]<br />
<br />
Primer used:[[Team:LMU-Munich/Schedule/pduA_fwd| pduA fwd]],[[Team:LMU-Munich/Schedule/mpduA_rev| mpduA rev]] expected product size: bp<br />
<br />
<br />
<b>PCR12b: replication of the Pdu-Operon with mutagenesis [ ] </b><br />
[[Image:PCR12bP.jpg]]<br />
<br />
<br />
Primer used:[[Team:LMU-Munich/Schedule/mpduA_fwd| mpduA fwd]],[[Team:LMU-Munich/Schedule/pduU_rev|pduU rev]] expected product size: bp<br />
<br />
<br />
<b>PCR13: Joining PCR of the Pdu-Operon [ ] </b><br />
[[Image:PCR131517P.jpg]]<br />
<br />
Primer used:[[Team:LMU-Munich/Schedule/pduA_fwd| pduA fwd]],[[Team:LMU-Munich/Schedule/pduU_rev|pduU rev]] expected product size: bp<br />
<br />
<br />
<b>PCR14a: replication of the Pdu-Operon with mutagenesis [ ] </b><br />
[[Image:PCR14aP.jpg]]<br />
<br />
Primer used:[[Team:LMU-Munich/Schedule/pduA_fwd| pduA fwd]],[[Team:LMU-Munich/Schedule/mpduB_rev|mpduB rev]] expected product size: bp<br />
<br />
<br />
<b>PCR14b: replication of the Pdu-Operon with mutagenesis [ ] </b><br />
[[Image:PCR14bP.jpg]]<br />
<br />
Primer used:[[Team:LMU-Munich/Schedule/mpduB_fwd| mpduB fwd]],[[Team:LMU-Munich/Schedule/pduU_rev|pduU rev]] expected product size: bp<br />
<br />
<br />
<b>PCR15: Joining PCR of the Pdu-Operon [ ] </b><br />
[[Image:PCR131517P.jpg]]<br />
<br />
Primer used:[[Team:LMU-Munich/Schedule/pduA_fwd|pduA fwd]],[[Team:LMU-Munich/Schedule/pduU_rev|pduU rev]] expected product size: bp<br />
<br />
<br />
<b>PCR16a: replication of the Pdu-Operon with mutagenesis [ ] </b><br />
[[Image:PCR16aP.jpg]]<br />
<br />
Primer used:[[Team:LMU-Munich/Schedule/pduA_fwd|pduA fwd]],[[Team:LMU-Munich/Schedule/mpduJ_rev|mpduJ rev]] expected product size: bp<br />
<br />
<br />
<b>PCR16b: replication of the Pdu-Operon with mutagenesis [ ] </b><br />
[[Image:PCR16bP.jpg]]<br />
<br />
Primer used:[[Team:LMU-Munich/Schedule/mpduJ_fwd|mpduJ fwd]],[[Team:LMU-Munich/Schedule/pduU_rev|pduU rev]] expected product size: bp<br />
<br />
<br />
<b>PCR17: Joining PCR of the Pdu-Operon [ ] </b><br />
[[Image:PCR131517P.jpg]]<br />
<br />
Primer used:[[Team:LMU-Munich/Schedule/pduA_fwd|pduA fwd]],[[Team:LMU-Munich/Schedule/pduU_rev|pduU rev]] expected product size: bp<br />
<br />
{{:Team:LMU-Munich/Templates/Page Footer}}</div>TobiBhttp://2010.igem.org/Team:LMU-Munich/PathwayTeam:LMU-Munich/Pathway2010-10-25T13:58:19Z<p>TobiB: /* The pathway project */</p>
<hr />
<div>{{:Team:LMU-Munich/Templates/Page Header}}<br />
<br />
== The Pathway project ==<br />
<br />
In this project we want to make a heterologous transformation of a bacterial microcompartment (= BMC), which contains enzymes to synthesize azobenzene derivatives.<br />
<br />
It is only possible to synthesize these organic compounds, when protecting the cell from the cytotoxic intermediates. This protection is provided by the proteinacious microcompartment (also called metabolosome or BMC).<br />
<br />
Azobenzene derivatives are not only used as dyes but also as molecular switches for the field of chemical biology and optogenetics (genetically engineered organisms, which can be altered through optical stimulation).<br />
<br />
BMCs are found in a variety of prokaryotic organisms and is naturally involved in substrate channeling for example as in a carboxysome. <br />
<br />
<br />
{{:Team:LMU-Munich/Templates/Page Footer}}</div>TobiBhttp://2010.igem.org/Team:LMU-Munich/Functional_PrincipleTeam:LMU-Munich/Functional Principle2010-10-25T13:57:52Z<p>TobiB: /* Project 2: Pathway */</p>
<hr />
<div>{{:Team:LMU-Munich/Templates/Page Header}}<br />
==The Pathway project==<br />
<br />
<br />
Project “Pathway” involves the creation of an artificial metabolic pathway for the synthesis of azobenzene derivates in E. coli. This would be accomplished by expressing the required enzymes, encased in a proteinaceous bacterial microcompartment. This construct is necessary in order to shield the cell from toxic intermediates which would otherwise make this biosynthesis impossible. Azobenzene derivates are interesting in the field of biochemistry because of their properties as synthetic molecular switches.<br />
<br />
{{:Team:LMU-Munich/Templates/Page Footer}}</div>TobiBhttp://2010.igem.org/Team:LMU-Munich/Functional_PrincipleTeam:LMU-Munich/Functional Principle2010-10-25T13:55:57Z<p>TobiB: /* Project 2: Pathway */</p>
<hr />
<div>{{:Team:LMU-Munich/Templates/Page Header}}<br />
==Project 2: Pathway==<br />
<br />
<br />
Project “Pathway” involves the creation of an artificial metabolic pathway for the synthesis of azobenzene derivates in E. coli. This would be accomplished by expressing the required enzymes, encased in a proteinaceous bacterial microcompartment. This construct is necessary in order to shield the cell from toxic intermediates which would otherwise make this biosynthesis impossible. Azobenzene derivates are interesting in the field of biochemistry because of their properties as synthetic molecular switches.<br />
<br />
{{:Team:LMU-Munich/Templates/Page Footer}}</div>TobiBhttp://2010.igem.org/Team:LMU-Munich/Functional_PrincipleTeam:LMU-Munich/Functional Principle2010-10-25T13:55:06Z<p>TobiB: </p>
<hr />
<div>{{:Team:LMU-Munich/Templates/Page Header}}<br />
==Project 2: Pathway==<br />
<br />
Project “Pathway” involves the creation of an artificial metabolic pathway for the synthesis of azobenzene derivates in E. coli. This would be accomplished by expressing the required enzymes, encased in a proteinaceous bacterial microcompartment. This construct is necessary in order to shield the cell from toxic intermediates which would otherwise make this biosynthesis impossible. Azobenzene derivates are interesting in the field of biochemistry because of their properties as synthetic molecular switches.<br />
{{:Team:LMU-Munich/Templates/Page Footer}}</div>TobiBhttp://2010.igem.org/Team:LMU-Munich/Functional_PrincipleTeam:LMU-Munich/Functional Principle2010-10-25T13:38:07Z<p>TobiB: Undo revision 144434 by TobiB (Talk)</p>
<hr />
<div>{{:Team:LMU-Munich/Templates/Page Header}}<br />
==Bacterial Microcompartment (BMC)/ Metabolosome==<br />
<br />
==Targeting of Enzymes to the BMC==<br />
==The Chemistry==<br />
[[Image:BMCAzo.gif|1000px|Bild vom BMC zum herstellen von Azobenzoles]]<br />
<br />
==Azobenzene derivates and their usage== <br />
{{:Team:LMU-Munich/Templates/Page Footer}}</div>TobiBhttp://2010.igem.org/Team:LMU-Munich/Functional_PrincipleTeam:LMU-Munich/Functional Principle2010-10-25T13:37:22Z<p>TobiB: </p>
<hr />
<div>{{:Team:LMU-Munich/Templates/Page Header}}<br />
<br />
{{:Team:LMU-Munich/Templates/Page Footer}}</div>TobiBhttp://2010.igem.org/Team:LMU-Munich/SequencesTeam:LMU-Munich/Sequences2010-10-25T13:35:17Z<p>TobiB: </p>
<hr />
<div>{{:Team:LMU-Munich/Templates/Page Header}}<br />
<p>[[Team:LMU-Munich/Sequences/Pdu Operon|Pdu Operon]]</p><br />
<p>[[Team:LMU-Munich/Sequences/PduD|Pdu D]]</p><br />
<p>[[Team:LMU-Munich/Sequences/PduC|Pdu C]]</p><br />
<p>[[Team:LMU-Munich/Sequences/AurF|AurF]]</p><br />
<p>[[Team:LMU-Munich/Sequences/LctO|LctO]]</p><br />
{{:Team:LMU-Munich/Templates/Page Footer}}</div>TobiBhttp://2010.igem.org/Team:LMU-Munich/SequencesTeam:LMU-Munich/Sequences2010-10-25T13:34:51Z<p>TobiB: </p>
<hr />
<div>{{:Team:LMU-Munich/Templates/Page Header}}<br />
<br />
{{:Team:LMU-Munich/Templates/Page Footer}}</div>TobiBhttp://2010.igem.org/Team:LMU-Munich/SafetyTeam:LMU-Munich/Safety2010-10-22T14:49:19Z<p>TobiB: /* Safety */</p>
<hr />
<div><!-- Include the next line at the beginning of every page --><br />
{{:Team:LMU-Munich/Templates/Page Header}}<br />
<br />
==Safety==<br />
<br />
1. Would any of your project ideas raise safety issues in terms of:<br />
:* researcher safety,<br />
:* public safety, or<br />
:* environmental safety?<br />
<br />
<br />
None of our project ideas raised any safety issues – whether for the researcher, nor for the publicity and environment.<br />
<br />
To assure this in first place, every participant took part in a general safety meeting in order to join the iGEM-Team. This meeting dealt with the common safety rules concerning optimal laboratory conditions and the general behavior in the lab.<br />
In order to protect ourselves, we mostly worked with non-hazardous chemicals and organisms like apathogenic E. coli strains such as DH5 alpha or BL21. Besides, we wore a lab coat and single-use gloves. When working with e.g. liquid N<sub>2</sub>, we wore goggles as well.<br />
When operating with dangerous substances (as e. g. ethidiumbromide), we additionally wore nitrile gloves. Furthermore dangerous substances were stored and handled in desigenated room in order to assure the safety of the researchers.<br />
<br />
For the protection of the public and the environment against hazardous substances, our garbage as well as our liquid waste was sterilized by autoclavation. Before leaving the laboratory, every researcher has cleaned and disinfected his/her hands. Moreover, we let the windows closed and did not throw jeopardy stuff into the sink.<br />
<br />
<br />
----<br />
<br />
<br />
2. Do any of the new BioBrick parts (or devices) that you made this year raise any safety issues? If yes,<br />
:* did you document these issues in the Registry?<br />
:* how did you manage to handle the safety issue?<br />
:* How could other teams learn from your experience?<br />
<br />
<br />
None of our biobricks did raise any safety issues. Therefore we didn't need to document anything.<br />
<br />
<br />
----<br />
<br />
<br />
3. Is there a local biosafety group, committee, or review board at your institution?<br />
:* If yes, what does your local biosafety group think about your project?<br />
:* If no, which specific biosafety rules or guidelines do you have to consider in your country?<br />
<br />
<br />
Germany has signed and ratified the ''Cartagena Biosafety Protocol''. This protocol ensures safe handling, use and transfer of genetically modified organisms. Furthermore, we have our own laws and guidelines for biosafety here. For example, all laboratories which are handling GMOs have a designated biosafety level, which is stated in a genetic engineering decree (Gentechnik Sicherheitsverordnung).<br />
<br />
<br />
----<br />
<br />
<br />
4. Do you have any other ideas how to deal with safety issues that could be useful for future iGEM competitions?<br />
How could parts, devices and systems be made even safer through biosafety engineering?<br />
<br />
<br />
To improve the safety while working with (hazardous) biobricks a new kind of biobrick backbone should be established. Every potentially pathogenic or hazardous biobrick should be cloned in a special backbone containing the sequences of the present backbones (ORI, resistance cassette,restriction sites ...) AND an inducible killing gene cassette. This killing cassette (e.g. ccdB in E. coli with an exchanged promotor) is induced by a normaly absent reagent that could easily be added in case of contamination. Adding this reagent would result in an expression of the killing gene, which leads to the death of the pathogenic cells containing the biobrick plasmid.<br />
<br />
<br />
<br />
<!-- Include the next line at the end of every page --><br />
{{:Team:LMU-Munich/Templates/Page Footer}}</div>TobiBhttp://2010.igem.org/Team:LMU-Munich/SafetyTeam:LMU-Munich/Safety2010-10-22T14:48:43Z<p>TobiB: /* Safety */</p>
<hr />
<div><!-- Include the next line at the beginning of every page --><br />
{{:Team:LMU-Munich/Templates/Page Header}}<br />
<br />
==Safety==<br />
<br />
1. Would any of your project ideas raise safety issues in terms of:<br />
:* researcher safety,<br />
:* public safety, or<br />
:* environmental safety?<br />
<br />
<br />
None of our project ideas raised any safety issues – whether for the researcher, nor for the publicity and environment.<br />
<br />
To assure this in first place, every participant took part in a general safety meeting in order to join the iGEM-Team. This meeting dealt with the common safety rules concerning optimal laboratory conditions and the general behavior in the lab.<br />
In order to protect ourselves, we mostly worked with non-hazardous chemicals and organisms like apathogenic E. coli strains such as DH5 alpha or BL21. Besides, we wore a lab coat and single-use gloves. When working with e.g. liquid N<sub>2</sub>, we wore goggles as well.<br />
When operating with dangerous substances (as e. g. ethidiumbromide), we additionally wore nitrile gloves. Furthermore dangerous substances were stored and handled in desigenated room in order to assure the safety of the researchers.<br />
<br />
For the protection of the public and the environment against hazardous substances, our garbage as well as our liquid waste was sterilized by autoclavation. Before leaving the laboratory, every researcher has cleaned and disinfected his/her hands. Moreover, we let the windows closed and did not throw jeopardy stuff into the sink.<br />
<br />
<br />
----<br />
<br />
<br />
2. Do any of the new BioBrick parts (or devices) that you made this year raise any safety issues? If yes,<br />
:* did you document these issues in the Registry?<br />
:* how did you manage to handle the safety issue?<br />
:* How could other teams learn from your experience?<br />
<br />
<br />
None of our biobricks did raise any safety issues. Therefore we didn't need to document anything.<br />
<br />
<br />
----<br />
<br />
<br />
3. Is there a local biosafety group, committee, or review board at your institution?<br />
:* If yes, what does your local biosafety group think about your project?<br />
:* If no, which specific biosafety rules or guidelines do you have to consider in your country?<br />
<br />
<br />
Germany has signed and ratified the ''Cartagena Biosafety Protocol''. This protocol ensures safe handling, use and transfer of genetically modified organisms. Furthermore, we have our own laws and guidelines for biosafety here. For example, all laboratories which are handling GMOs have a designated biosafety level, which is stated in a genetic engineering decree (Gentechnik Sicherheitsverordnung).<br />
<br />
<br />
----<br />
<br />
<br />
4. Do you have any other ideas how to deal with safety issues that could be useful for future iGEM competitions?<br />
How could parts, devices and systems be made even safer through biosafety engineering?<br />
<br />
<br />
:*To improve the safety while working with (hazardous) biobricks a new kind of biobrick backbone should be established. Every potentially pathogenic or hazardous biobrick should be cloned in a special backbone containing the sequences of the present backbones (ORI, resistance cassette,restriction sites ...) AND an inducible killing gene cassette. This killing cassette (e.g. ccdB in E. coli with an exchanged promotor) is induced by a normaly absent reagent that could easily be added in case of contamination. Adding this reagent would result in an expression of the killing gene, which leads to the death of the pathogenic cells containing the biobrick plasmid.<br />
<br />
<br />
<br />
<!-- Include the next line at the end of every page --><br />
{{:Team:LMU-Munich/Templates/Page Footer}}</div>TobiBhttp://2010.igem.org/Team:LMU-Munich/SafetyTeam:LMU-Munich/Safety2010-10-22T14:48:01Z<p>TobiB: /* Safety */</p>
<hr />
<div><!-- Include the next line at the beginning of every page --><br />
{{:Team:LMU-Munich/Templates/Page Header}}<br />
<br />
==Safety==<br />
<br />
1. Would any of your project ideas raise safety issues in terms of:<br />
:* researcher safety,<br />
:* public safety, or<br />
:* environmental safety?<br />
<br />
<br />
None of our project ideas raised any safety issues – whether for the researcher, nor for the publicity and environment.<br />
<br />
To assure this in first place, every participant took part in a general safety meeting in order to join the iGEM-Team. This meeting dealt with the common safety rules concerning optimal laboratory conditions and the general behavior in the lab.<br />
In order to protect ourselves, we mostly worked with non-hazardous chemicals and organisms like apathogenic E. coli strains such as DH5 alpha or BL21. Besides, we wore a lab coat and single-use gloves. When working with e.g. liquid N<sub>2</sub>, we wore goggles as well.<br />
When operating with dangerous substances (as e. g. ethidiumbromide), we additionally wore nitrile gloves. Furthermore dangerous substances were stored and handled in desigenated room in order to assure the safety of the researchers.<br />
<br />
For the protection of the public and the environment against hazardous substances, our garbage as well as our liquid waste was sterilized by autoclavation. Before leaving the laboratory, every researcher has cleaned and disinfected his/her hands. Moreover, we let the windows closed and did not throw jeopardy stuff into the sink.<br />
<br />
<br />
----<br />
<br />
<br />
2. Do any of the new BioBrick parts (or devices) that you made this year raise any safety issues? If yes,<br />
:* did you document these issues in the Registry?<br />
:* how did you manage to handle the safety issue?<br />
:* How could other teams learn from your experience?<br />
<br />
<br />
None of our biobricks did raise any safety issues. Therefore we didn't need to document anything.<br />
<br />
<br />
----<br />
<br />
<br />
3. Is there a local biosafety group, committee, or review board at your institution?<br />
:* If yes, what does your local biosafety group think about your project?<br />
:* If no, which specific biosafety rules or guidelines do you have to consider in your country?<br />
<br />
<br />
Germany has signed and ratified the ''Cartagena Biosafety Protocol''. This protocol ensures safe handling, use and transfer of genetically modified organisms. Furthermore, we have our own laws and guidelines for biosafety here. For example, all laboratories which are handling GMOs have a designated biosafety level, which is stated in a genetic engineering decree (Gentechnik Sicherheitsverordnung).<br />
<br />
<br />
----<br />
<br />
<br />
4. Do you have any other ideas how to deal with safety issues that could be useful for future iGEM competitions?<br />
How could parts, devices and systems be made even safer through biosafety engineering?<br />
<br />
<br />
:*To improve the safety while working with (hazardous) biobricks a new kind of biobrick backbone should be established. Every potentially pathogenic or hazardous biobrick should be cloned in a special backbone containing the sequences of the present backbones (ORI, resistance cassette,restriction sites ...) AND an inducible killing gene cassette. This killing cassette (e.g. ccdB in E. coli with an exchanged promotor) is induced by a normaly absent reagent that could easily be added in case of contamination. Adding this reagent would result in an expression of the killing gene, which leads to the death of the pathogenic cells containing the biobrick plasmid.<br />
<br />
<br />
commercial available and commonly used restriction enzyme should be named in the registry. This restriction enzyme should be able to cut the biobrick DNA sequence several times in order to inactivate it. In case of contamination the samples containing the crucial DNA could easily be destroyed by simply adding the enzyme plus the corresponding buffer to inhibit the spread of pathogenic materials.<br />
<br />
:*Furthermore a new kind of plasmid backbone <br />
<br />
<!-- Include the next line at the end of every page --><br />
{{:Team:LMU-Munich/Templates/Page Footer}}</div>TobiBhttp://2010.igem.org/Team:LMU-Munich/SafetyTeam:LMU-Munich/Safety2010-10-22T14:34:45Z<p>TobiB: /* Safety */</p>
<hr />
<div><!-- Include the next line at the beginning of every page --><br />
{{:Team:LMU-Munich/Templates/Page Header}}<br />
<br />
==Safety==<br />
<br />
1. Would any of your project ideas raise safety issues in terms of:<br />
:* researcher safety,<br />
:* public safety, or<br />
:* environmental safety?<br />
<br />
<br />
None of our project ideas raised any safety issues – whether for the researcher, nor for the publicity and environment.<br />
<br />
To assure this in first place, every participant took part in a general safety meeting in order to join the iGEM-Team. This meeting dealt with the common safety rules concerning optimal laboratory conditions and the general behavior in the lab.<br />
In order to protect ourselves, we mostly worked with non-hazardous chemicals and organisms like apathogenic E. coli strains such as DH5 alpha or BL21. Besides, we wore a lab coat and single-use gloves. When working with e.g. liquid N<sub>2</sub>, we wore goggles as well.<br />
When operating with dangerous substances (as e. g. ethidiumbromide), we additionally wore nitrile gloves. Furthermore dangerous substances were stored and handled in desigenated room in order to assure the safety of the researchers.<br />
<br />
For the protection of the public and the environment against hazardous substances, our garbage as well as our liquid waste was sterilized by autoclavation. Before leaving the laboratory, every researcher has cleaned and disinfected his/her hands. Moreover, we let the windows closed and did not throw jeopardy stuff into the sink.<br />
<br />
<br />
----<br />
<br />
<br />
2. Do any of the new BioBrick parts (or devices) that you made this year raise any safety issues? If yes,<br />
:* did you document these issues in the Registry?<br />
:* how did you manage to handle the safety issue?<br />
:* How could other teams learn from your experience?<br />
<br />
<br />
None of our biobricks did raise any safety issues. Therefore we didn't need to document anything.<br />
<br />
<br />
----<br />
<br />
<br />
3. Is there a local biosafety group, committee, or review board at your institution?<br />
:* If yes, what does your local biosafety group think about your project?<br />
:* If no, which specific biosafety rules or guidelines do you have to consider in your country?<br />
<br />
<br />
Germany has signed and ratified the ''Cartagena Biosafety Protocol''. This protocol ensures safe handling, use and transfer of genetically modified organisms. Furthermore, we have our own laws and guidelines for biosafety here. For example, all laboratories which are handling GMOs have a designated biosafety level, which is stated in a genetic engineering decree (Gentechnik Sicherheitsverordnung).<br />
<br />
<br />
----<br />
<br />
<br />
4. Do you have any other ideas how to deal with safety issues that could be useful for future iGEM competitions?<br />
How could parts, devices and systems be made even safer through biosafety engineering?<br />
<br />
<br />
To improve the safety while working with (hazardous) biobricks a commercial available and commonly used restriction enzyme should be named in the registry. This restriction enzyme should be able to cut the biobrick DNA sequence several times in order to inactivate it. In case of contamination the samples containing the crucial DNA could easily be destroyed by simply adding the enzyme plus the corresponding buffer to inhibit the spread of pathogenic materials.<br />
<br />
<br />
<!-- Include the next line at the end of every page --><br />
{{:Team:LMU-Munich/Templates/Page Footer}}</div>TobiBhttp://2010.igem.org/Team:LMU-Munich/SafetyTeam:LMU-Munich/Safety2010-10-22T14:07:10Z<p>TobiB: /* Safety */</p>
<hr />
<div><!-- Include the next line at the beginning of every page --><br />
{{:Team:LMU-Munich/Templates/Page Header}}<br />
<br />
==Safety==<br />
<br />
1. Would any of your project ideas raise safety issues in terms of:<br />
:* researcher safety,<br />
:* public safety, or<br />
:* environmental safety?<br />
<br />
<br />
None of our project ideas raised any safety issues – whether for the researcher, nor for the publicity and environment.<br />
<br />
To assure this in first place, every participant took part in a general safety meeting in order to join the iGEM-Team. This meeting dealt with the common safety rules concerning optimal laboratory conditions and the general behavior in the lab.<br />
In order to protect ourselves, we mostly worked with non-hazardous chemicals and organisms like apathogenic E. coli strains such as DH5 alpha or BL21. Besides, we wore a lab coat and single-use gloves. When working with e.g. liquid N<sub>2</sub>, we wore goggles as well.<br />
When operating with dangerous substances (as e. g. ethidiumbromide), we additionally wore nitrile gloves. Furthermore dangerous substances were stored and handled in desigenated room in order to assure the safety of the researchers.<br />
<br />
For the protection of the public and the environment against hazardous substances, our garbage as well as our liquid waste was sterilized by autoclavation. Before leaving the laboratory, every researcher has cleaned and disinfected his/her hands. Moreover, we let the windows closed and did not throw jeopardy stuff into the sink.<br />
<br />
<br />
----<br />
<br />
<br />
2. Do any of the new BioBrick parts (or devices) that you made this year raise any safety issues? If yes,<br />
:* did you document these issues in the Registry?<br />
:* how did you manage to handle the safety issue?<br />
:* How could other teams learn from your experience?<br />
<br />
<br />
None of our biobricks did raise any safety issues. Therefore we didn't need to document anything.<br />
<br />
<br />
----<br />
<br />
<br />
3. Is there a local biosafety group, committee, or review board at your institution?<br />
:* If yes, what does your local biosafety group think about your project?<br />
:* If no, which specific biosafety rules or guidelines do you have to consider in your country?<br />
<br />
<br />
Germany has signed and ratified the ''Cartagena Biosafety Protocol''. This protocol ensures safe handling, use and transfer of genetically modified organisms. Furthermore, we have our own laws and guidelines for biosafety here. For example, all laboratories which are handling GMOs have a designated biosafety level, which is stated in a genetic engineering decree (Gentechnik Sicherheitsverordnung).<br />
<br />
<br />
----<br />
<br />
<br />
4. Do you have any other ideas how to deal with safety issues that could be useful for future iGEM competitions?<br />
How could parts, devices and systems be made even safer through biosafety engineering?<br />
<br />
<br />
text<br />
<br />
<br />
<!-- Include the next line at the end of every page --><br />
{{:Team:LMU-Munich/Templates/Page Footer}}</div>TobiBhttp://2010.igem.org/Team:LMU-Munich/SafetyTeam:LMU-Munich/Safety2010-10-22T14:06:15Z<p>TobiB: /* Safety */</p>
<hr />
<div><!-- Include the next line at the beginning of every page --><br />
{{:Team:LMU-Munich/Templates/Page Header}}<br />
<br />
==Safety==<br />
<br />
1. Would any of your project ideas raise safety issues in terms of:<br />
:* researcher safety,<br />
:* public safety, or<br />
:* environmental safety?<br />
<br />
<br />
None of our project ideas raised any safety issues – whether for the researcher, nor for the publicity and environment.<br />
<br />
To assure this in first place, every participant took part in a general safety meeting in order to join the iGEM-Team. This meeting dealt with the common safety rules concerning optimal laboratory conditions and the general behavior in the lab.<br />
In order to protect ourselves, we mostly worked with non-hazardous chemicals and organisms like apathogenic E. coli strains such as DH5 alpha or BL21. Besides, we wore a lab coat and single-use gloves. When working with e.g. liquid N<sub>2</sub>, we wore goggles as well.<br />
When operating with dangerous substances (as e. g. ethidiumbromide), we additionally wore nitrile gloves. Furthermore dangerous substances were stored and handled in desigenated room in order to assure the safety of the researchers.<br />
<br />
For the protection of the public and the environment against hazardous substances, our garbage as well as our liquid waste was sterilized by autoclavation. Before leaving the laboratory, every researcher has cleaned and disinfected his/her hands. Moreover, we let the windows closed and did not throw jeopardy stuff into the sink.<br />
<br />
<br />
----<br />
<br />
<br />
2. Do any of the new BioBrick parts (or devices) that you made this year raise any safety issues? If yes,<br />
:* did you document these issues in the Registry?<br />
:* how did you manage to handle the safety issue?<br />
:* How could other teams learn from your experience?<br />
<br />
None of our biobricks did raise any safety issues. Therefore we didn't need to document anything.<br />
<br />
----<br />
<br />
<br />
3. Is there a local biosafety group, committee, or review board at your institution?<br />
:* If yes, what does your local biosafety group think about your project?<br />
:* If no, which specific biosafety rules or guidelines do you have to consider in your country?<br />
<br />
<br />
Germany has signed and ratified the ''Cartagena Biosafety Protocol''. This protocol ensures safe handling, use and transfer of genetically modified organisms. Furthermore, we have our own laws and guidelines for biosafety here. For example, all laboratories which are handling GMOs have a designated biosafety level, which is stated in a genetic engineering decree (Gentechnik Sicherheitsverordnung).<br />
<br />
----<br />
<br />
<br />
4. Do you have any other ideas how to deal with safety issues that could be useful for future iGEM competitions?<br />
How could parts, devices and systems be made even safer through biosafety engineering?<br />
<br />
<br />
text<br />
<br />
<br />
<!-- Include the next line at the end of every page --><br />
{{:Team:LMU-Munich/Templates/Page Footer}}</div>TobiBhttp://2010.igem.org/Team:LMU-Munich/SafetyTeam:LMU-Munich/Safety2010-10-22T14:05:06Z<p>TobiB: /* Safety */</p>
<hr />
<div><!-- Include the next line at the beginning of every page --><br />
{{:Team:LMU-Munich/Templates/Page Header}}<br />
<br />
==Safety==<br />
<br />
1. Would any of your project ideas raise safety issues in terms of:<br />
:* researcher safety,<br />
:* public safety, or<br />
:* environmental safety?<br />
<br />
<br />
None of our project ideas raised any safety issues – whether for the researcher, nor for the publicity and environment.<br />
<br />
To assure this in first place, every participant took part in a general safety meeting in order to join the iGEM-Team. This meeting dealt with the common safety rules concerning optimal laboratory conditions and the general behavior in the lab.<br />
In order to protect ourselves, we mostly worked with non-hazardous chemicals and organisms like apathogenic E. coli strains such as DH5 alpha or BL21. Besides, we wore a lab coat and single-use gloves. When working with e.g. liquid N<sub>2</sub>, we wore goggles as well.<br />
When operating with dangerous substances (as e. g. ethidiumbromide), we additionally wore nitrile gloves. Furthermore dangerous substances were stored and handled in desigenated room in order to assure the safety of the researchers.<br />
<br />
For the protection of the public and the environment against hazardous substances, our garbage as well as our liquid waste was sterilized by autoclavation. Before leaving the laboratory, every researcher has cleaned and disinfected his/her hands. Moreover, we let the windows closed and did not throw jeopardy stuff into the sink.<br />
<br />
----<br />
<br />
<br />
2. Do any of the new BioBrick parts (or devices) that you made this year raise any safety issues? If yes,<br />
:* did you document these issues in the Registry?<br />
:* how did you manage to handle the safety issue?<br />
:* How could other teams learn from your experience?<br />
<br />
None of our biobricks did raise any safety issues. Therefore we didn't need to document anything.<br />
<br />
----<br />
<br />
<br />
3. Is there a local biosafety group, committee, or review board at your institution?<br />
:* If yes, what does your local biosafety group think about your project?<br />
:* If no, which specific biosafety rules or guidelines do you have to consider in your country?<br />
<br />
<br />
Germany has signed and ratified the ''Cartagena Biosafety Protocol''. This protocol ensures safe handling, use and transfer of genetically modified organisms. Furthermore, we have our own laws and guidelines for biosafety here. For example, all laboratories which are handling GMOs have a designated biosafety level, which is stated in a genetic engineering decree (Gentechnik Sicherheitsverordnung).<br />
<br />
----<br />
<br />
<br />
4. Do you have any other ideas how to deal with safety issues that could be useful for future iGEM competitions?<br />
How could parts, devices and systems be made even safer through biosafety engineering?<br />
<br />
<br />
text<br />
<br />
<br />
<!-- Include the next line at the end of every page --><br />
{{:Team:LMU-Munich/Templates/Page Footer}}</div>TobiBhttp://2010.igem.org/Team:LMU-Munich/TeamTeam:LMU-Munich/Team2010-09-17T16:17:52Z<p>TobiB: /* Undergrads */</p>
<hr />
<div>__NOTOC__<br />
<!-- Include the next line at the beginning of every page --><br />
{{:Team:LMU-Munich/Templates/Page Header}}<br />
<br />
'''Team LMU IGEM 2010'''<br />
[[Image:LMU-Munich_team.png|center|600px|Our team picture]]<br />
[[Image:TeamLMU.JPG|center|600px|Also our team]]<br />
<br />
<!-- {|align="justify" --><br />
<!-- |You can write a background of your team here. Give us a background of your team, the members, etc. Or tell us more about something of your choosing. --><br />
<!-- |[[Image:LMU-Munich_logo.png|200px|right|frame]] --><br />
<!-- |- --><br />
<!-- | --><br />
<!-- ''Tell us more about your project. Give us background. Use this is the abstract of your project. Be descriptive but concise (1-2 paragraphs)'' --><br />
<!-- |[[Image:LMU-Munich_team.png|right|frame|Your team picture]] --><br />
<!-- |- --><br />
<!-- | --><br />
<!-- |align="center"|[[Team:LMU-Munich | Team Example]] --><br />
<!-- |} --><br />
<br />
<!--- The Mission, Experiments ---><br />
<!--{| style="color:#1b2c8a;background-color:#0c6;" cellpadding="3" cellspacing="1" border="1" bordercolor="#fff" width="62%" align="center" --><br />
<!--!align="center"|[[Team:LMU-Munich|Home]] --><br />
<!--!align="center"|[[Team:LMU-Munich/Team|Team]] --><br />
<!--!align="center"|[https://igem.org/Team.cgi?year=2010&team_name=LMU-Munich Official Team Profile] --><br />
<!--!align="center"|[[Team:LMU-Munich/Project|Project]] --><br />
<!--!align="center"|[[Team:LMU-Munich/Parts|Parts Submitted to the Registry]] --><br />
<!--!align="center"|[[Team:LMU-Munich/Modeling|Modeling]] --><br />
<!--!align="center"|[[Team:LMU-Munich/Notebook|Notebook]] --><br />
<!--!align="center"|[[Team:LMU-Munich/Safety|Safety]] --><br />
<!--|} --><br />
<br />
== '''Who we are''' ==<br />
<br />
We are a team constisting of biologists, biochemists, chemists and bioinformatics and four faculty advisors... The LMU team is competing for the first time.<br />
<br />
=== Advisors ===<br />
<br />
<div align="center"><br />
<gallery><br />
Image: Böttger.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/AngelikaBöttger Prof. Dr. Angelika Böttger] :''' Department Biologie II/ Cell and Developmental Biology<br />
Image:Jung.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/KirstenJung Prof. Dr. Kirsten Jung] :''' Head of the Division of Microbiology <br />
Image:Mascher.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/ThorstenMascher Prof. Dr. Thorsten Mascher] :''' Department Biologie I/ Microbiology<br />
</gallery><br />
</div><br />
<div align="center"><br />
<gallery><br />
Image:Tresch.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/AchimTresch Dr. Achim Tresch] :''' Computational Biology and Regulatory Networks<br />
Image:Akman.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/KemalAkman Kemal Akman] :''' Bioinformatics<br />
</gallery><br />
</div><br />
<br />
=== Undergrads ===<br />
<br />
<br />
<div align="center"><br />
<gallery><br />
Image:Julia3.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Julia Julia Bartels] :''' expected BSc Biology, ApoControl, Pathway <br />
Image:Tobi.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Tobi Tobias Bauer] :''' BSc Biology, Pathway <br />
Image:Alexander Buschle.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Alex Alexander Buschle] :''' BSc Biology, ApoControl<br />
Image:Benny.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Benny Benjamin Clanner] :''' Chemistry and Biochemistry, pharmaceutical sciences, Pathway <br />
</gallery><br />
<gallery><br />
Image:Maria.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Maria Maria Katharina Drexler] :''' BSc Biology, ApoControl<br />
Image:ErikFumi.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Erik Erik Fumi] :''' Chemistry and Biochemistry, Pathway<br />
Image:Tatyana.jpg|'''[https://2010.igem.org/User:Tatyana Tatyana Goldberg] :''' BSc Bioinformatics, ApoControl<br />
Image:Franzi.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Franzi Franziska Häfele] :''' expected BSc Biology, ApoControl<br />
</gallery><br />
<gallery><br />
Image:Corinna.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Corinna Corinna Hofer] :''' BSc Biology, ApoControl<br />
Image:Nicolas.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Nicky Nicolas Keller] :''' Biology, Law, ApoControl, Pathway<br />
Image:Laura2.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Laura Laura Kleinknecht] :''' BSc Biology, ApoControl <br />
Image:Christina.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Christina Christina Krönauer] :''' expected BSc Biology, Pathway <br />
</gallery><br />
<gallery><br />
Image:Marisa.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Marisa Marisa Kurz] :''' Chemistry and Biochemistry, Pathway <br />
Image:Jens Popken.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Jens Jens Popken] :''' Biology, Pathway <br />
Image:Jara2.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Jara Jara Radeck] :''' Biology, ApoControl<br />
Image:Emanuel.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Emanuel Emanuel Stiegeler] :''' BSc Biology, Pathway <br />
</gallery><br />
<gallery><br />
Image:Geli.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Geli Angelika Vetter] :''' Biology, ApoControl<br />
Image:Sabine Wagner.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Bine Sabine Wagner] :''' Biology, ApoControl, Pathway <br />
Image:Grace.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Grace Mengzhe Wang (Grace)] :''' Biology, ApoControl<br />
Image:Lisa.png|'''[https://2010.igem.org/Team:LMU-Munich/Team/Lisa Lisa-Maria Zink] :''' Biology, ApoControl<br />
</gallery><br />
</div><br />
<br />
== '''Who is in charge of what?''' ==<br />
<br />
<p>Press: Nicolas Keller, Marisa Kurz</p><br />
<p>Sponsors: Sabine Wagner, Franziska Häfele</p><br />
<p>Pathway: Tobias Bauer, Emanuel Stiegeler, Benny Clanner</p><br />
<p>Apo-Control: Mengzhe Wang („Grace“), Julia Bartels</p><br />
<p>Homepage: Tatyana Goldberg, Jens Popken</p><br />
<p>Coordination/Organisation: Jara Radeck</p><br />
<p>Contact: igemlmu(at)yahoo(dot)de</p><br />
<br />
== '''What we did''' ==<br />
<br />
(Provide proper attribution for all work)<br />
<br />
== '''Where we are from''' ==<br />
<br />
We are students at Ludwigs-Maximilians-University in Munich, Germany.<br />
<br />
<html><br />
<!-- hitwebcounter Code START --><br />
<br><br />
<br><br />
<div align="center"><br />
<a href="http://www.hitwebcounter.com/internetcountercontact.php" target="_blank"><br />
<img src="http://hitwebcounter.com/counter/counter.php?page=102444&style=0006&nbdigits=5&type=page&initCount=0" title="Statistics Counters" Alt="Statistics Counters" border="0" ><br />
</a><br />
<br><br />
<a href="http://www.hitwebcounter.com/" title="Our Web Counter" <br />
target="_blank" style="font-family: Geneva, Arial, Helvetica, sans-serif; <br />
font-size: 11px; color: #8A8A8A; text-decoration: none;"><strong>Our Web Counter</strong><br />
</a> <!-- hitwebcounter.com --> <br />
</html><br />
<br />
<!-- Include the next line at the end of every page --><br />
{{:Team:LMU-Munich/Templates/Page Footer}}</div>TobiBhttp://2010.igem.org/Team:LMU-Munich/Team/TobiTeam:LMU-Munich/Team/Tobi2010-09-16T11:17:29Z<p>TobiB: /* (Research) Interests */</p>
<hr />
<div>{{:Team:LMU-Munich/Templates/Page Header}}<br />
[[Image:Tobi1.jpg|thumb|right|Tobias Bauer]]<br />
==Contact Info==<br />
*Tobias Bauer<br />
*Ludwig Maximilians University (LMU)<br />
==Education==<br />
* 2010 BSc in Biology, LMU<br />
==(Research) Interests==<br />
# microbiology<br />
# world domination<br />
{{:Team:LMU-Munich/Templates/Page Footer}}</div>TobiBhttp://2010.igem.org/Team:LMU-Munich/TeamTeam:LMU-Munich/Team2010-09-02T12:09:11Z<p>TobiB: /* Undergrads */</p>
<hr />
<div>__NOTOC__<br />
<!-- Include the next line at the beginning of every page --><br />
{{:Team:LMU-Munich/Templates/Page Header}}<br />
<br />
'''Team LMU IGEM 2010'''<br />
[[Image:LMU-Munich_team.png|center|600px|Our team picture]]<br />
[[Image:TeamLMU.JPG|center|600px|Also our team]]<br />
<br />
<!-- {|align="justify" --><br />
<!-- |You can write a background of your team here. Give us a background of your team, the members, etc. Or tell us more about something of your choosing. --><br />
<!-- |[[Image:LMU-Munich_logo.png|200px|right|frame]] --><br />
<!-- |- --><br />
<!-- | --><br />
<!-- ''Tell us more about your project. Give us background. Use this is the abstract of your project. Be descriptive but concise (1-2 paragraphs)'' --><br />
<!-- |[[Image:LMU-Munich_team.png|right|frame|Your team picture]] --><br />
<!-- |- --><br />
<!-- | --><br />
<!-- |align="center"|[[Team:LMU-Munich | Team Example]] --><br />
<!-- |} --><br />
<br />
<!--- The Mission, Experiments ---><br />
<!--{| style="color:#1b2c8a;background-color:#0c6;" cellpadding="3" cellspacing="1" border="1" bordercolor="#fff" width="62%" align="center" --><br />
<!--!align="center"|[[Team:LMU-Munich|Home]] --><br />
<!--!align="center"|[[Team:LMU-Munich/Team|Team]] --><br />
<!--!align="center"|[https://igem.org/Team.cgi?year=2010&team_name=LMU-Munich Official Team Profile] --><br />
<!--!align="center"|[[Team:LMU-Munich/Project|Project]] --><br />
<!--!align="center"|[[Team:LMU-Munich/Parts|Parts Submitted to the Registry]] --><br />
<!--!align="center"|[[Team:LMU-Munich/Modeling|Modeling]] --><br />
<!--!align="center"|[[Team:LMU-Munich/Notebook|Notebook]] --><br />
<!--!align="center"|[[Team:LMU-Munich/Safety|Safety]] --><br />
<!--|} --><br />
<br />
== '''Who we are''' ==<br />
<br />
We are a team constisting of biologists, biochemists, chemists and bioinformatics and four faculty advisors... The LMU team is competing for the first time.<br />
<br />
=== Advisors ===<br />
<br />
<div align="center"><br />
<gallery><br />
Image: Böttger.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/AngelikaBöttger Prof. Dr. Angelika Böttger] :''' Department Biologie II/ Cell and Developmental Biology<br />
Image:Jung.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/KirstenJung Prof. Dr. Kirsten Jung] :''' Head of the Division of Microbiology <br />
Image:Mascher.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/ThorstenMascher Prof. Dr. Thorsten Mascher] :''' Department Biologie I/ Microbiology<br />
Image:Tresch.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/AchimTresch Dr. Achim Tresch] :''' Computational Biology and Regulatory Networks<br />
</gallery><br />
</div><br />
<br />
=== Undergrads ===<br />
<br />
<br />
<div align="center"><br />
<gallery><br />
Image:Julia3.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Julia Julia Bartels] :''' expected BSc Biology, ApoControl, Pathway <br />
Image:Tobi.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Tobi Tobias Bauer] :''' Biology, Pathway <br />
Image:Alexander Buschle.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Alex Alexander Buschle] :''' Biology, ApoControl<br />
Image:Benny.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Benny Benjamin Clanner] :''' Chemistry and Biochemistry, pharmaceutical sciences, Pathway <br />
</gallery><br />
<gallery><br />
Image:Maria.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Maria Maria Drexler] :''' Biology, ApoControl<br />
Image:ErikFumi.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Erik Erik Fumi] :''' Chemistry and Biochemistry, Pathway<br />
Image:Tatyana.jpg|'''[https://2010.igem.org/User:Tatyana Tatyana Goldberg] :''' B.Sc. Bioinformatics<br />
Image:Franzi.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Franzi Franziska Häfele] :''' expected BSc Biology, ApoControl<br />
</gallery><br />
<gallery><br />
Image:Corinna.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Corinna Corinna Hofer] :''' Biology, ApoControl<br />
Image:Nicolas.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Nicky Nicolas Keller] :''' Biology, Law, ApoControl, Pathway<br />
Image:Laura2.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Laura Laura Kleinknecht] :''' Biology, ApoControl <br />
Image:Christina.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Christina Christina Krönauer] :''' expected BSc Biology, Pathway <br />
</gallery><br />
<gallery><br />
Image:Marisa.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Marisa Marisa Kurz] :''' Chemistry and Biochemistry, Pathway <br />
Image:Jens Popken.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Jens Jens Popken] :''' Biology, Pathway <br />
Image:Jara2.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Jara Jara Radeck] :''' Biology, ApoControl<br />
Image:Emanuel.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Emanuel Emanuel Stiegeler] :''' BCs Biology, Pathway <br />
</gallery><br />
<gallery><br />
Image:Geli.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Geli Angelika Vetter] :''' Biology, ApoControl<br />
Image:Sabine Wagner.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Bine Sabine Wagner] :''' Biology, ApoControl, Pathway <br />
Image:Grace.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Grace Mengzhe Wang (Grace)] :''' Biology, ApoControl<br />
Image:Lisa.png|'''[https://2010.igem.org/Team:LMU-Munich/Team/Lisa Lisa-Maria Zink] :''' Biology, ApoControl<br />
</gallery><br />
</div><br />
<br />
== '''Who is in charge of what?''' ==<br />
<br />
<p>Press: Nicolas Keller, Marisa Kurz</p><br />
<p>Sponsors: Sabine Wagner, Franziska Häfele</p><br />
<p>Pathway: Tobias Bauer, Emanuel Stiegeler, Benny Clanner</p><br />
<p>Apo-Control: Mengzhe Wang („Grace“), Julia Bartels</p><br />
<p>Homepage: Tatyana Goldberg, Jens Popken</p><br />
<p>Coordination/Organisation: Jara Radeck</p><br />
<p>Contact: igemlmu(at)yahoo(dot)de</p><br />
<br />
== '''What we did''' ==<br />
<br />
(Provide proper attribution for all work)<br />
<br />
== '''Where we are from''' ==<br />
<br />
We are students from the Ludwigs-Maximilians-University in Munich, Germany.<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<!-- Include the next line at the end of every page --><br />
{{:Team:LMU-Munich/Templates/Page Footer}}</div>TobiBhttp://2010.igem.org/Team:LMU-Munich/TeamTeam:LMU-Munich/Team2010-09-02T12:08:54Z<p>TobiB: /* Undergrads */</p>
<hr />
<div>__NOTOC__<br />
<!-- Include the next line at the beginning of every page --><br />
{{:Team:LMU-Munich/Templates/Page Header}}<br />
<br />
'''Team LMU IGEM 2010'''<br />
[[Image:LMU-Munich_team.png|center|600px|Our team picture]]<br />
[[Image:TeamLMU.JPG|center|600px|Also our team]]<br />
<br />
<!-- {|align="justify" --><br />
<!-- |You can write a background of your team here. Give us a background of your team, the members, etc. Or tell us more about something of your choosing. --><br />
<!-- |[[Image:LMU-Munich_logo.png|200px|right|frame]] --><br />
<!-- |- --><br />
<!-- | --><br />
<!-- ''Tell us more about your project. Give us background. Use this is the abstract of your project. Be descriptive but concise (1-2 paragraphs)'' --><br />
<!-- |[[Image:LMU-Munich_team.png|right|frame|Your team picture]] --><br />
<!-- |- --><br />
<!-- | --><br />
<!-- |align="center"|[[Team:LMU-Munich | Team Example]] --><br />
<!-- |} --><br />
<br />
<!--- The Mission, Experiments ---><br />
<!--{| style="color:#1b2c8a;background-color:#0c6;" cellpadding="3" cellspacing="1" border="1" bordercolor="#fff" width="62%" align="center" --><br />
<!--!align="center"|[[Team:LMU-Munich|Home]] --><br />
<!--!align="center"|[[Team:LMU-Munich/Team|Team]] --><br />
<!--!align="center"|[https://igem.org/Team.cgi?year=2010&team_name=LMU-Munich Official Team Profile] --><br />
<!--!align="center"|[[Team:LMU-Munich/Project|Project]] --><br />
<!--!align="center"|[[Team:LMU-Munich/Parts|Parts Submitted to the Registry]] --><br />
<!--!align="center"|[[Team:LMU-Munich/Modeling|Modeling]] --><br />
<!--!align="center"|[[Team:LMU-Munich/Notebook|Notebook]] --><br />
<!--!align="center"|[[Team:LMU-Munich/Safety|Safety]] --><br />
<!--|} --><br />
<br />
== '''Who we are''' ==<br />
<br />
We are a team constisting of biologists, biochemists, chemists and bioinformatics and four faculty advisors... The LMU team is competing for the first time.<br />
<br />
=== Advisors ===<br />
<br />
<div align="center"><br />
<gallery><br />
Image: Böttger.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/AngelikaBöttger Prof. Dr. Angelika Böttger] :''' Department Biologie II/ Cell and Developmental Biology<br />
Image:Jung.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/KirstenJung Prof. Dr. Kirsten Jung] :''' Head of the Division of Microbiology <br />
Image:Mascher.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/ThorstenMascher Prof. Dr. Thorsten Mascher] :''' Department Biologie I/ Microbiology<br />
Image:Tresch.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/AchimTresch Dr. Achim Tresch] :''' Computational Biology and Regulatory Networks<br />
</gallery><br />
</div><br />
<br />
=== Undergrads ===<br />
<br />
<br />
<div align="center"><br />
<gallery><br />
Image:Julia3.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Julia Julia Bartels] :''' expected BSc Biology, ApoControl, Pathway <br />
Image:Tobi.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Tobi Tobias Bauer] :''' Biology, Pathway <br />
Image:Alexander Buschle.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Alex Alexander Buschle] :''' Biology, ApoControl<br />
Image:Benny.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Benny Benjamin Clanner] :''' Chemistry and Biochemistry, pharmaceutical sciences, Pathway <br />
</gallery><br />
<gallery><br />
Image:Maria.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Maria Maria Drexler] :''' Biology, ApoControl<br />
Image:Erik2.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Erik Erik Fumi] :''' Chemistry and Biochemistry, Pathway<br />
Image:Tatyana.jpg|'''[https://2010.igem.org/User:Tatyana Tatyana Goldberg] :''' B.Sc. Bioinformatics<br />
Image:Franzi.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Franzi Franziska Häfele] :''' expected BSc Biology, ApoControl<br />
</gallery><br />
<gallery><br />
Image:Corinna.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Corinna Corinna Hofer] :''' Biology, ApoControl<br />
Image:Nicolas.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Nicky Nicolas Keller] :''' Biology, Law, ApoControl, Pathway<br />
Image:Laura2.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Laura Laura Kleinknecht] :''' Biology, ApoControl <br />
Image:Christina.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Christina Christina Krönauer] :''' expected BSc Biology, Pathway <br />
</gallery><br />
<gallery><br />
Image:Marisa.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Marisa Marisa Kurz] :''' Chemistry and Biochemistry, Pathway <br />
Image:Jens Popken.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Jens Jens Popken] :''' Biology, Pathway <br />
Image:Jara2.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Jara Jara Radeck] :''' Biology, ApoControl<br />
Image:Emanuel.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Emanuel Emanuel Stiegeler] :''' BCs Biology, Pathway <br />
</gallery><br />
<gallery><br />
Image:Geli.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Geli Angelika Vetter] :''' Biology, ApoControl<br />
Image:Sabine Wagner.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Bine Sabine Wagner] :''' Biology, ApoControl, Pathway <br />
Image:Grace.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Grace Mengzhe Wang (Grace)] :''' Biology, ApoControl<br />
Image:Lisa.png|'''[https://2010.igem.org/Team:LMU-Munich/Team/Lisa Lisa-Maria Zink] :''' Biology, ApoControl<br />
</gallery><br />
</div><br />
<br />
== '''Who is in charge of what?''' ==<br />
<br />
<p>Press: Nicolas Keller, Marisa Kurz</p><br />
<p>Sponsors: Sabine Wagner, Franziska Häfele</p><br />
<p>Pathway: Tobias Bauer, Emanuel Stiegeler, Benny Clanner</p><br />
<p>Apo-Control: Mengzhe Wang („Grace“), Julia Bartels</p><br />
<p>Homepage: Tatyana Goldberg, Jens Popken</p><br />
<p>Coordination/Organisation: Jara Radeck</p><br />
<p>Contact: igemlmu(at)yahoo(dot)de</p><br />
<br />
== '''What we did''' ==<br />
<br />
(Provide proper attribution for all work)<br />
<br />
== '''Where we are from''' ==<br />
<br />
We are students from the Ludwigs-Maximilians-University in Munich, Germany.<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<!-- Include the next line at the end of every page --><br />
{{:Team:LMU-Munich/Templates/Page Footer}}</div>TobiBhttp://2010.igem.org/Team:LMU-Munich/TeamTeam:LMU-Munich/Team2010-09-02T11:54:16Z<p>TobiB: /* Undergrads */</p>
<hr />
<div>__NOTOC__<br />
<!-- Include the next line at the beginning of every page --><br />
{{:Team:LMU-Munich/Templates/Page Header}}<br />
<br />
'''Team LMU IGEM 2010'''<br />
[[Image:LMU-Munich_team.png|center|600px|Our team picture]]<br />
[[Image:TeamLMU.JPG|center|600px|Also our team]]<br />
<br />
<!-- {|align="justify" --><br />
<!-- |You can write a background of your team here. Give us a background of your team, the members, etc. Or tell us more about something of your choosing. --><br />
<!-- |[[Image:LMU-Munich_logo.png|200px|right|frame]] --><br />
<!-- |- --><br />
<!-- | --><br />
<!-- ''Tell us more about your project. Give us background. Use this is the abstract of your project. Be descriptive but concise (1-2 paragraphs)'' --><br />
<!-- |[[Image:LMU-Munich_team.png|right|frame|Your team picture]] --><br />
<!-- |- --><br />
<!-- | --><br />
<!-- |align="center"|[[Team:LMU-Munich | Team Example]] --><br />
<!-- |} --><br />
<br />
<!--- The Mission, Experiments ---><br />
<!--{| style="color:#1b2c8a;background-color:#0c6;" cellpadding="3" cellspacing="1" border="1" bordercolor="#fff" width="62%" align="center" --><br />
<!--!align="center"|[[Team:LMU-Munich|Home]] --><br />
<!--!align="center"|[[Team:LMU-Munich/Team|Team]] --><br />
<!--!align="center"|[https://igem.org/Team.cgi?year=2010&team_name=LMU-Munich Official Team Profile] --><br />
<!--!align="center"|[[Team:LMU-Munich/Project|Project]] --><br />
<!--!align="center"|[[Team:LMU-Munich/Parts|Parts Submitted to the Registry]] --><br />
<!--!align="center"|[[Team:LMU-Munich/Modeling|Modeling]] --><br />
<!--!align="center"|[[Team:LMU-Munich/Notebook|Notebook]] --><br />
<!--!align="center"|[[Team:LMU-Munich/Safety|Safety]] --><br />
<!--|} --><br />
<br />
== '''Who we are''' ==<br />
<br />
We are a team constisting of biologists, biochemists, chemists and bioinformatics and four faculty advisors... The LMU team is competing for the first time.<br />
<br />
=== Advisors ===<br />
<br />
<div align="center"><br />
<gallery><br />
Image: Böttger.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/AngelikaBöttger Prof. Dr. Angelika Böttger] :''' Department Biologie II/ Cell and Developmental Biology<br />
Image:Jung.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/KirstenJung Prof. Dr. Kirsten Jung] :''' Head of the Division of Microbiology <br />
Image:Mascher.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/ThorstenMascher Prof. Dr. Thorsten Mascher] :''' Department Biologie I/ Microbiology<br />
Image:Tresch.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/AchimTresch Dr. Achim Tresch] :''' Computational Biology and Regulatory Networks<br />
</gallery><br />
</div><br />
<br />
=== Undergrads ===<br />
<br />
<br />
<div align="center"><br />
<gallery><br />
Image:Julia3.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Julia Julia Bartels] :''' expected BSc Biology, ApoControl, Pathway <br />
Image:Tobi.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Tobi Tobias Bauer] :''' Biology, Pathway <br />
Image:Alexander Buschle.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Alex Alexander Buschle] :''' Biology, ApoControl<br />
Image:Benny.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Benny Benjamin Clanner] :''' Chemistry and Biochemistry, pharmaceutical sciences, Pathway <br />
</gallery><br />
<gallery><br />
Image:Maria.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Maria Maria Drexler] :''' Biology, ApoControl<br />
Image:ErikFumi.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Erik Erik Fumi] :''' Chemistry and Biochemistry, Pathway<br />
Image:Tatyana.jpg|'''[https://2010.igem.org/User:Tatyana Tatyana Goldberg] :''' B.Sc. Bioinformatics<br />
Image:Franzi.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Franzi Franziska Häfele] :''' expected BSc Biology, ApoControl<br />
</gallery><br />
<gallery><br />
Image:Corinna.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Corinna Corinna Hofer] :''' Biology, ApoControl<br />
Image:Nicolas.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Nicky Nicolas Keller] :''' Biology, Law, ApoControl, Pathway<br />
Image:Laura2.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Laura Laura Kleinknecht] :''' Biology, ApoControl <br />
Image:Christina.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Christina Christina Krönauer] :''' expected BSc Biology, Pathway <br />
</gallery><br />
<gallery><br />
Image:Marisa.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Marisa Marisa Kurz] :''' Chemistry and Biochemistry, Pathway <br />
Image:Jens Popken.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Jens Jens Popken] :''' Biology, Pathway <br />
Image:Jara2.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Jara Jara Radeck] :''' Biology, ApoControl<br />
Image:Emanuel.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Emanuel Emanuel Stiegeler] :''' BCs Biology, Pathway <br />
</gallery><br />
<gallery><br />
Image:Geli.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Geli Angelika Vetter] :''' Biology, ApoControl<br />
Image:Sabine Wagner.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Bine Sabine Wagner] :''' Biology, ApoControl, Pathway <br />
Image:Grace.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Grace Mengzhe Wang (Grace)] :''' Biology, ApoControl<br />
Image:Lisa.png|'''[https://2010.igem.org/Team:LMU-Munich/Team/Lisa Lisa-Maria Zink] :''' Biology, ApoControl<br />
</gallery><br />
</div><br />
<br />
== '''Who is in charge of what?''' ==<br />
<br />
<p>Press: Nicolas Keller, Marisa Kurz</p><br />
<p>Sponsors: Sabine Wagner, Franziska Häfele</p><br />
<p>Pathway: Tobias Bauer, Emanuel Stiegeler, Benny Clanner</p><br />
<p>Apo-Control: Mengzhe Wang („Grace“), Julia Bartels</p><br />
<p>Homepage: Tatyana Goldberg, Jens Popken</p><br />
<p>Coordination/Organisation: Jara Radeck</p><br />
<p>Contact: igemlmu(at)yahoo(dot)de</p><br />
<br />
== '''What we did''' ==<br />
<br />
(Provide proper attribution for all work)<br />
<br />
== '''Where we are from''' ==<br />
<br />
We are students from the Ludwigs-Maximilians-University in Munich, Germany.<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<!-- Include the next line at the end of every page --><br />
{{:Team:LMU-Munich/Templates/Page Footer}}</div>TobiBhttp://2010.igem.org/File:ErikFumi.jpgFile:ErikFumi.jpg2010-09-02T11:52:51Z<p>TobiB: </p>
<hr />
<div></div>TobiBhttp://2010.igem.org/Team:LMU-Munich/Team/ErikTeam:LMU-Munich/Team/Erik2010-09-02T11:52:12Z<p>TobiB: </p>
<hr />
<div>{{:Team:LMU-Munich/Templates/Page Header}}<br />
[[Image:ErikFumi.jpg|thumb|right|Erik Fumi]]<br />
==Contact Info==<br />
*Erik Fumi<br />
*Ludwig Maximilians University (LMU)<br />
==Education==<br />
* 2010 BSc in Biology, LMU<br />
==(Research) Interests==<br />
# Biochemistry<br />
<br />
{{:Team:LMU-Munich/Templates/Page Footer}}</div>TobiBhttp://2010.igem.org/Team:LMU-Munich/Team/ErikTeam:LMU-Munich/Team/Erik2010-09-02T11:51:23Z<p>TobiB: </p>
<hr />
<div>{{:Team:LMU-Munich/Templates/Page Header}}<br />
[[Image:Erik.jpg|thumb|right|Erik Fumi]]<br />
==Contact Info==<br />
*Erik Fumi<br />
*Ludwig Maximilians University (LMU)<br />
==Education==<br />
* 2010 BSc in Biology, LMU<br />
==(Research) Interests==<br />
# Biochemistry<br />
<br />
{{:Team:LMU-Munich/Templates/Page Footer}}</div>TobiBhttp://2010.igem.org/File:Tobi1.jpgFile:Tobi1.jpg2010-08-26T10:45:21Z<p>TobiB: </p>
<hr />
<div></div>TobiBhttp://2010.igem.org/Team:LMU-Munich/Team/TobiTeam:LMU-Munich/Team/Tobi2010-08-26T10:44:20Z<p>TobiB: New page: {{:Team:LMU-Munich/Templates/Page Header}} Tobias Bauer ==Contact Info== *Tobias Bauer *Ludwig Maximilians University (LMU) ==Education== * 2010 BSc in Biol...</p>
<hr />
<div>{{:Team:LMU-Munich/Templates/Page Header}}<br />
[[Image:Tobi1.jpg|thumb|right|Tobias Bauer]]<br />
==Contact Info==<br />
*Tobias Bauer<br />
*Ludwig Maximilians University (LMU)<br />
==Education==<br />
* 2010 BSc in Biology, LMU<br />
==(Research) Interests==<br />
# Microbiology<br />
<br />
{{:Team:LMU-Munich/Templates/Page Footer}}</div>TobiBhttp://2010.igem.org/Team:LMU-Munich/TeamTeam:LMU-Munich/Team2010-08-26T10:23:52Z<p>TobiB: /* Undergrads */</p>
<hr />
<div>__NOTOC__<br />
<!-- Include the next line at the beginning of every page --><br />
{{:Team:LMU-Munich/Templates/Page Header}}<br />
<br />
'''Team LMU IGEM 2010'''<br />
[[Image:LMU-Munich_team.png|center|600px|Our team picture]]<br />
[[Image:TeamLMU.JPG|center|600px|Also our team]]<br />
<br />
<!-- {|align="justify" --><br />
<!-- |You can write a background of your team here. Give us a background of your team, the members, etc. Or tell us more about something of your choosing. --><br />
<!-- |[[Image:LMU-Munich_logo.png|200px|right|frame]] --><br />
<!-- |- --><br />
<!-- | --><br />
<!-- ''Tell us more about your project. Give us background. Use this is the abstract of your project. Be descriptive but concise (1-2 paragraphs)'' --><br />
<!-- |[[Image:LMU-Munich_team.png|right|frame|Your team picture]] --><br />
<!-- |- --><br />
<!-- | --><br />
<!-- |align="center"|[[Team:LMU-Munich | Team Example]] --><br />
<!-- |} --><br />
<br />
<!--- The Mission, Experiments ---><br />
<!--{| style="color:#1b2c8a;background-color:#0c6;" cellpadding="3" cellspacing="1" border="1" bordercolor="#fff" width="62%" align="center" --><br />
<!--!align="center"|[[Team:LMU-Munich|Home]] --><br />
<!--!align="center"|[[Team:LMU-Munich/Team|Team]] --><br />
<!--!align="center"|[https://igem.org/Team.cgi?year=2010&team_name=LMU-Munich Official Team Profile] --><br />
<!--!align="center"|[[Team:LMU-Munich/Project|Project]] --><br />
<!--!align="center"|[[Team:LMU-Munich/Parts|Parts Submitted to the Registry]] --><br />
<!--!align="center"|[[Team:LMU-Munich/Modeling|Modeling]] --><br />
<!--!align="center"|[[Team:LMU-Munich/Notebook|Notebook]] --><br />
<!--!align="center"|[[Team:LMU-Munich/Safety|Safety]] --><br />
<!--|} --><br />
<br />
== '''Who we are''' ==<br />
<br />
We are a team constisting of biologists, biochemists, chemists and bioinformatics and four faculty advisors... The LMU team is competing for the first time.<br />
<br />
=== Advisors ===<br />
<br />
<div align="center"><br />
<gallery><br />
Image: Böttger.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/AngelikaBöttger Prof. Dr. Angelika Böttger] :''' Department BiologieII/ Cell and Developmental Biology<br />
Image:Jung.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/KirstenJung Prof. Dr. Kirsten Jung] :''' Head of the Division of Microbiology <br />
Image:Mascher.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/ThorstenMascher Prof. Dr. Thorsten Mascher] :''' Department BiologieI/ Microbiology<br />
Image:Tresch.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/AchimTresch Dr. Achim Tresch] :''' Computational Biology and Regulatory Networks<br />
</gallery><br />
</div><br />
<br />
=== Undergrads ===<br />
<br />
<div align="center"><br />
<gallery><br />
Image:Julia3.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Julia Julia Bartels] :''' expected BSc Biology, ApoControl, Pathway <br />
Image:Tobi.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Tobi Tobias Bauer] :''' Biology, Pathway <br />
Image:Alexander Buschle.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Alex Alexander Buschle] :''' Biology, ApoControl<br />
Image:Benny.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Benny Benjamin Clanner] :''' Chemistry and Biochemistry, pharmaceutical sciences, Pathway <br />
</gallery><br />
<gallery><br />
Image:Maria.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Maria Maria Drexler] :''' Biology, ApoControl<br />
Image:Erik2.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Erik Erik Fumi] :''' Chemistry and Biochemistry, Pathway<br />
Image:Tatyana.jpg|'''[https://2010.igem.org/User:Tatyana Tatyana Goldberg] :''' B.Sc. Bioinformatics<br />
Image:Franzi.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Franzi Franziska Häfele] :''' Biology, ApoControl<br />
</gallery><br />
<gallery><br />
Image:Corinna.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Corinna Corinna Hofer] :''' Biology, ApoControl<br />
Image:Nicolas.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Nicky Nicolas Keller] :''' Biology, Law, ApoControl, Pathway<br />
Image:Laura2.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Laura Laura Kleinknecht] :''' Biology, ApoControl <br />
Image:Christina.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Christina Christina Krönauer] :''' expected BSc Biology, Pathway <br />
</gallery><br />
<gallery><br />
Image:Marisa.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Marisa Marisa Kurz] :''' Chemistry and Biochemistry, Pathway <br />
Image:Jens Popken.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Jens Jens Popken] :''' Biology, Pathway <br />
Image:Jara2.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Jara Jara Radeck] :''' Biology, ApoControl<br />
Image:Emanuel.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Emanuel Emanuel Stiegeler] :''' BCs Biology, Pathway <br />
</gallery><br />
<gallery><br />
Image:File.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Geli Angelika Vetter] :''' Biology, ApoControl<br />
Image:Sabine Wagner.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Bine Sabine Wagner] :''' Biology, ApoControl, Pathway <br />
Image:Grace.jpg|'''[https://2010.igem.org/Team:LMU-Munich/Team/Grace Mengzhe Wang (Grace)] :''' Biology, ApoControl<br />
Image:Lisa.png|'''[https://2010.igem.org/Team:LMU-Munich/Team/Lisa Lisa-Maria Zink] :''' Biology, ApoControl<br />
</gallery><br />
</div><br />
<br />
== '''Who is in charge of what?''' ==<br />
<br />
<p>Press: Nicolas Keller, Marisa Kurz</p><br />
<p>Sponsors: Sabine Wagner</p><br />
<p>Pathway: Tobias Bauer, Emanuel Stiegeler, Benjamin Clanner</p><br />
<p>Apo-Control: Mengzhe Wang („Grace“), Julia Bartels</p><br />
<p>Homepage: Tatyana Goldberg, Jens Popken</p><br />
<p>Coordination/Organisation: Jara Radeck</p><br />
<p>Contact: igemlmu(at)yahoo(dot)de</p><br />
<br />
== '''What we did''' ==<br />
<br />
(Provide proper attribution for all work)<br />
<br />
<br />
<br />
== '''Where we are from''' ==<br />
<br />
we are from Munich<br />
<br />
<!-- Include the next line at the end of every page --><br />
{{:Team:LMU-Munich/Templates/Page Footer}}</div>TobiBhttp://2010.igem.org/File:Tobi.jpgFile:Tobi.jpg2010-08-26T10:21:37Z<p>TobiB: </p>
<hr />
<div></div>TobiB